Agency for Care Effectiveness — Scientific publications https://www.ace-hta.gov.sg/resources/scientific-publications/ View all scientific publications here. en Wed, 14 Oct 2026 12:49:50 +0800 Isomer (https://www.isomer.gov.sg) Using Patient Perspectives in Health Technology Assessment for Rare Conditions: A Singapore Case Studyhttps://isomer-user-content.by.gov.sg/68/378a6e7e-7ff7-4ae7-90b6-4a3ccbf4f858/6_using-patient-perspectives-in-health-technology-assessment-for-rare-conditions-a-singapore-cas.pdfurn:isomer:resource:406569Fri, 04 Sep 2026 00:00:00 +080013th Annual HTAsiaLink Conference 2026Taipei, TaiwanOral presentations Bridging HTA to Practice: A Structured Framework to Assess Implementation Readiness in Public Healthcare Institutions (PHIs) for Subsidised Medical Technologieshttps://isomer-user-content.by.gov.sg/68/46981bd9-6d8d-4293-8174-4e39e422eed5/4_bridging-HTA-to-practice-a-structured-framework-to-assess-implementation-readiness-in-public-h.pdfurn:isomer:resource:406565Fri, 04 Sep 2026 00:00:00 +080013th Annual HTAsiaLink Conference 2026Taipei, TaiwanOral presentations Optimising Topic Prioritisation for HTA in Medical Technologies in Singapore - The Development, Validation and Feasibility of Process Enhancementshttps://isomer-user-content.by.gov.sg/68/08dfe919-8e70-4623-9f30-cb2d4d2a70b8/5_optimising-topic-prioritisation-for-HTA-in-medical-technologies-in-singapore-the-development-v.pdfurn:isomer:resource:406567Fri, 04 Sep 2026 00:00:00 +080013th Annual HTAsiaLink Conference 2026Taipei, TaiwanOral presentations Right Technology, Right Time? Assessing the Horizon Scanning Approach to Medical Technology Foresight to Support Adoption in Singaporehttps://isomer-user-content.by.gov.sg/68/61f633cd-18f7-4d11-8660-2dded1434626/3_right-technology-right-time-assessing-the-horizon-scanning-approach-to-medical-technology-fore.pdfurn:isomer:resource:406562Fri, 04 Sep 2026 00:00:00 +080013th Annual HTAsiaLink Conference 2026Taipei, TaiwanConference posters Cost-effectiveness Analysis of Tumour-treating Fields in Combination with Adjuvant Temozolomide for Treating Patients with Newly Diagnosed Glioblastoma in Singaporehttps://isomer-user-content.by.gov.sg/68/789a1612-08a6-4bd1-9d33-2f9cd759e6d8/2_cost-effectiveness-analysis-of-tumour-treating-fields-in.pdfurn:isomer:resource:406556Fri, 04 Sep 2026 00:00:00 +080013th Annual HTAsiaLink Conference 2026Taipei, TaiwanConference posters Patient Involvement in Health Technology Assessment: a New Process in Singaporehttps://isomer-user-content.by.gov.sg/68/7e459b4a-c3eb-4ddc-978b-0966f31af003/patient-involvement-in-health-technology-assessment-a-new-process-in-singapore.pdfurn:isomer:resource:191798Vol. 42 - Issue 1Wed, 18 Feb 2026 00:00:00 +0800International Journal of Technology Assessment in Health CareJournal publications Establishing a Consumer Panel to Inform Health Technology Assessment Processes and Policy: Impact and Insights from Singapore’s Experiencehttps://isomer-user-content.by.gov.sg/68/158b841a-3d8c-4d20-b87d-2b4f351ce842/establishing-a-consumer-panel-to-inform-health-technology-assessment-processes-and-policy-impact.pdfurn:isomer:resource:191796Vol. 42 - Issue 1Mon, 19 Jan 2026 00:00:00 +0800International Journal of Technology Assessment in Health CareJournal publications Exploratory Insights from a Survey to Inform Development of a Strategy for Clinical Guidelines Training in Singaporehttps://isomer-user-content.by.gov.sg/68/df0aae44-34fc-44d0-aa01-34127b7ca219/ETPO029_2025_GuidelineTraining.pdfurn:isomer:resource:133405Wed, 29 Oct 2025 00:00:00 +0800Evidence Implementation Summit (EIS) 2025Melbourne, AustraliaConference posters Cost-Effective Intervention Thresholds for Treating Patients with Osteopenia with Oral Bisphosphonates in Singaporehttps://isomer-user-content.by.gov.sg/68/ddf92b45-2ca3-4864-8fe4-b4dfd140bce3/ETPO020_2025_osteopeniathresholds.pdfurn:isomer:resource:97243Thu, 16 Oct 2025 00:00:00 +0800Appropriate and Value-Based Care Conference 2025Singapore, SingaporeConference posters Synergising Development of Guidelines and AVBC Indicators for CHF: A Multi-Pronged, Patient-Centred Approachhttps://isomer-user-content.by.gov.sg/68/53484087-87b5-424d-bbbd-d99667367eae/ETPO019_2025_chfavbcupdated.pdfurn:isomer:resource:97241Thu, 16 Oct 2025 00:00:00 +0800Appropriate and Value-Based Care Conference 2025Singapore, SingaporeConference posters A little red dot's story: Singapore's journey of translating evidence to practicehttps://isomer-user-content.by.gov.sg/68/de812a46-bcb8-41a5-974d-24e12387800c/ETPO028_2025_GIN%20plenary.pdfurn:isomer:resource:97411Fri, 19 Sep 2025 00:00:00 +0800Guidelines International Network (GIN) 2025Geneva, SwitzerlandPlenary Defining guidelines impact: the development of an impact planning toolhttps://isomer-user-content.by.gov.sg/68/6e00ae0f-73bf-4494-9f68-b17c4d6cceb6/ETPO018_2025_guidelineimpact.pdfurn:isomer:resource:93074Wed, 17 Sep 2025 00:00:00 +0800Guidelines International Network (GIN) 2025Geneva, SwitzerlandConference posters Improving Congestive Heart Failure Care: A Use-Case for Appropriate and Value-Based Care in Singaporehttps://isomer-user-content.by.gov.sg/68/3edc195a-ee82-4033-8e5e-f320f9d4c123/ETPO016_2025_chfavbc.pdfurn:isomer:resource:93072Wed, 17 Sep 2025 00:00:00 +0800Guidelines International Network (GIN) 2025Geneva, SwitzerlandOral presentations Mapping the use of clinical guidelines by policymakers: insights and implicationshttps://isomer-user-content.by.gov.sg/68/69d9d8f5-2238-4db9-bac3-c11f083aa739/ETPO017_2025_mappinguseofguidelines.pdfurn:isomer:resource:93073Wed, 17 Sep 2025 00:00:00 +0800Guidelines International Network (GIN) 2025Geneva, SwitzerlandOral presentations Stakeholder Insights and Guideline Review to Inform Antimicrobial Management Guidelines for Respiratory Infections in Primary Care: A Qualitative Studhttps://isomer-user-content.by.gov.sg/68/84245245-2e8c-4a67-9df5-5bbc4862be35/ETPO015_2025_URTIquali.pdfurn:isomer:resource:93071Wed, 17 Sep 2025 00:00:00 +0800Guidelines International Network (GIN) 2025Geneva, SwitzerlandOral presentations Company-led submissions in Singapore: an updated analysishttps://isomer-user-content.by.gov.sg/68/02598853-ccb6-4469-9965-fbbdd61ad6e6/Poster_Presentation_O084.pdfurn:isomer:resource:88967Wed, 20 Aug 2025 00:00:00 +080012th Annual HTAsiaLink ConferenceSingapore, SingaporeConference posters Cost effectiveness analysis for transcatheter aortic valve implantation in aortic stenosis patients with intermediate surgical risk in Singaporehttps://isomer-user-content.by.gov.sg/68/42a28ec3-220f-45c2-b22b-0e9d4cf931b1/Poster_Presentation_E086.pdfurn:isomer:resource:88963Wed, 20 Aug 2025 00:00:00 +080012th Annual HTAsiaLink ConferenceSingapore, SingaporeConference posters Cost-effectiveness analysis of anti-amyloid monoclonal antibodies (anti-Aβ mAbs) for early Alzheimer’s Disease in Singaporehttps://isomer-user-content.by.gov.sg/68/360fb89a-1911-4813-9b3b-6b9288c5501b/Poster_Display_E093.pdfurn:isomer:resource:88964Wed, 20 Aug 2025 00:00:00 +080012th Annual HTAsiaLink ConferenceSingapore, SingaporeConference posters Developing a health technology assessment framework for digital health technologies in Singaporehttps://isomer-user-content.by.gov.sg/68/c1f39044-6d87-485b-bbeb-8b89e68338f8/Poster_Display_O143.pdfurn:isomer:resource:88971Wed, 20 Aug 2025 00:00:00 +080012th Annual HTAsiaLink ConferenceSingapore, SingaporeConference posters Piloting a key and facilitated gene approach to HTA of germline genetic testing for hereditary breast and ovarian cancer in Singaporehttps://isomer-user-content.by.gov.sg/68/8a48008e-e5ae-42a1-b12a-1b959fddf3b2/Poster_Display_O085.pdfurn:isomer:resource:88968Wed, 20 Aug 2025 00:00:00 +080012th Annual HTAsiaLink ConferenceSingapore, SingaporeConference posters Proactive stakeholder engagement facilitates clinical adoption and utilisation of the most affordable subsidised drugs in Singapore’s PHIshttps://isomer-user-content.by.gov.sg/68/ebe96236-1682-498d-b67f-82788db1d1aa/Poster_Presentation_O081.pdfurn:isomer:resource:88966Wed, 20 Aug 2025 00:00:00 +080012th Annual HTAsiaLink ConferenceSingapore, SingaporeConference posters Real-world impact of drug subsidy policy on P2Y12 inhibitors utilisation and clinical practice in Singaporehttps://isomer-user-content.by.gov.sg/68/b3cc4419-d72d-4ee6-a164-4f4d7a61a78a/Poster_Display_O106.pdfurn:isomer:resource:88969Wed, 20 Aug 2025 00:00:00 +080012th Annual HTAsiaLink ConferenceSingapore, SingaporeConference posters Scaling Up the Implant Subsidy List in Singapore: Processes Enabling Growth and Expansion In Its First Yearhttps://isomer-user-content.by.gov.sg/68/34260953-a681-44f3-8598-5632b46206ba/Poster_Display_O112.pdfurn:isomer:resource:88970Wed, 20 Aug 2025 00:00:00 +080012th Annual HTAsiaLink ConferenceSingapore, SingaporeConference posters What’s Trending? An Inaugural Multi-Stakeholder Effort to Identify Top Emerging Medical Technology Trends in Singapore’s Healthcare Systemhttps://isomer-user-content.by.gov.sg/68/42a28ec3-220f-45c2-b22b-0e9d4cf931b1/Poster_Presentation_E086.pdfurn:isomer:resource:88965Wed, 20 Aug 2025 00:00:00 +080012th Annual HTAsiaLink ConferenceSingapore, SingaporeConference posters Barriers and enablers for optimising ACEi/ARBs and using SGLT2i in early-stage CKD management: A qualitative study in primary carehttps://isomer-user-content.by.gov.sg/68/77d55179-9b46-414d-adf3-a9d57f05508d/ETPO014_2025_ckdquali.pdfurn:isomer:resource:97240Wed, 06 Aug 2025 00:00:00 +0800International Congress of Behavioural Medicine (ICBM) 2025Vienna, AustriaConference posters Educational outreach visits as an implementation strategy to optimise type 2 diabetes management in Singaporehttps://isomer-user-content.by.gov.sg/68/a8f9c60a-f8cf-4f88-b9e3-d2fe85ab418c/ETPO013_2025_t2dmevimplementation.pdfurn:isomer:resource:97239Wed, 06 Aug 2025 00:00:00 +0800International Congress of Behavioural Medicine (ICBM) 2025Vienna, AustriaConference posters Cost-Effectiveness of Ruxolitinib in Singapore for Patients with Chronic Graft-Versus-Host Diseasehttps://isomer-user-content.by.gov.sg/68/65283281-7879-4a05-832e-518967e6fac1/Cost-effectiveness%20of%20ruxolitinib%20in%20Singapore%20for%20patients%20with%20chronic%20graft-versus-host%20disea.pdfurn:isomer:resource:191799Vol. 25 - Issue 10Mon, 30 Jun 2025 00:00:00 +0800Expert Review of Pharmacoeconomics & Outcomes ResearchJournal publications How Innovative is the Innovation? Early Experience in Assessing the Innovativeness of Emerging Medical Technologies in Singaporehttps://isomer-user-content.by.gov.sg/68/d192f353-7857-419f-a7e2-538862837487/HTAi%202025_PosterSlide_Gan%20Hua%20Pey_289_How%20Innovative%20is%20the%20Innovation%20Early%20Experience%20in%20Assessing%20the%20Innovativeness%20of%20Emerging%20Medical%20Technologies%20in%20Singapore.pdfurn:isomer:resource:66301Wed, 18 Jun 2025 00:00:00 +0800Health Technology Assessment International (HTAi) 2025 Annual MeetingBuenos Aires, ArgentinaConference posters Incorporating Lived Experiences in HTA: Impact on Subsidy Recommendations for Continuous Glucose Monitoring Systems in Singaporehttps://isomer-user-content.by.gov.sg/68/2bebc11f-37de-4fad-ab89-c475f18832a1/HTAi2025_Oral_PingTeeTan_244_Incorporating%20Lived%20Experiences%20in%20Health%20Technology%20Assessment%20Impact%20on%20Subsidy%20Recommendations%20for%20Continuous%20Glucose%20Monitoring%20Systems%20in%20Singapore.pdfurn:isomer:resource:66303Wed, 18 Jun 2025 00:00:00 +0800Health Technology Assessment International (HTAi) 2025 Annual MeetingBuenos Aires, ArgentinaConference posters Tailored Health Technology Assessment Capacity Building: Co-Designing Training Resources For Patients And Caregivers In Singaporehttps://isomer-user-content.by.gov.sg/68/5879e5fd-d8bd-4401-a220-349a47176cad/2_HTAi2025_Poster_JenHunKoh_PingTeeTan_245_Tailored%20Health%20Technology%20Assessment%20Capacity%20Building%20Co-Designing%20Training%20Resources%20For%20Patients%20And%20Caregivers%20In%20Singapore.pdfurn:isomer:resource:66302Wed, 18 Jun 2025 00:00:00 +0800Health Technology Assessment International (HTAi) 2025 Annual MeetingBuenos Aires, ArgentinaConference posters A strategic framework for prioritising programmes to improve healthcare quality in Singaporehttps://isomer-user-content.by.gov.sg/68/81a0fca5-680f-45c0-863c-76bd8b5014fa/ETPO009_2024_acpframework.pdfurn:isomer:resource:97230Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicOral presentations Activities and materials that support HCP-facilitated patient education to improve asthma management in Singaporehttps://isomer-user-content.by.gov.sg/68/ffb8b2b7-362d-4322-8289-988b8dc2c1c1/ETPO011_2024_asthmaptedu.pdfurn:isomer:resource:97234Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicConference posters Assessing dementia care gaps to guide clinical guidance scoping and other implementation efforts – the Singapore experiencehttps://isomer-user-content.by.gov.sg/68/bc781324-afc4-470a-ab9d-b625fc55f4b7/ETPO002_2024_dementiacaregaps.pdfurn:isomer:resource:97204Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicOral presentations Development of antibiotic management guidelines tailored to the local context ─ experiences from Singaporehttps://isomer-user-content.by.gov.sg/68/f7916c18-2c87-41b4-84df-3c1c1248d2a5/ETPO005_2024_antibioticguidelinestailored.pdfurn:isomer:resource:97207Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicConference posters Evaluating hyperlipidemia management in Singapore: Leveraging population health data to assess feasibility of new clinical guidancehttps://isomer-user-content.by.gov.sg/68/f0c8cd12-6af4-448b-ab0a-3c93aaae2d82/ETPO001_2024_hyperlimidaemia_pophealthdata.pdfurn:isomer:resource:97191Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicOral presentations Exploring the role for patient decision aids in Singaporehttps://isomer-user-content.by.gov.sg/68/c238b99d-b1f7-4c0d-949d-6f2b298b0311/ETPO012_2024_pea.pdfurn:isomer:resource:97238Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicConference posters Involving healthcare professionals towards targeted scope of a clinical guidance on generalised anxiety disorder (GAD) in Singaporehttps://isomer-user-content.by.gov.sg/68/20bb7588-3bb5-4469-bbd5-dd31b19a5df3/ETPO004_2024_gadscoping.pdfurn:isomer:resource:97206Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicConference posters Optimising the update of clinical guidelines for venous thromboembolism (VTE) in Singapore: insights from early expert group engagementhttps://isomer-user-content.by.gov.sg/68/103a48de-253a-4a78-8b48-b952edad0da2/ETPO007_2024_vteguidelines.pdfurn:isomer:resource:97209Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicConference posters Promoting accessibility and adoption – An overview of the ACG dissemination strategies undertaken by the Evidence to Practice Office in ACEhttps://isomer-user-content.by.gov.sg/68/cdaba10a-eb42-47d5-8d85-7f0bdd5e31e1/ETPO008_2024_disseminationstrategies.pdfurn:isomer:resource:97210Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicConference posters Reviewing the role of educational outreach visits for type 2 diabetes management in Singapore – a pragmatic approachhttps://isomer-user-content.by.gov.sg/68/890bfac0-3a59-4536-a677-1dba0ae069f2/ETPO010__2024_t2dmev.pdfurn:isomer:resource:97232Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicConference posters Understanding challenges in primary care management of ischemic heart disease (IHD) to inform the scoping of a national clinical guidancehttps://isomer-user-content.by.gov.sg/68/38bee0d8-6f54-49a3-aae6-09a6a6a2e55a/ETPO003_2024_ihdscoping.pdfurn:isomer:resource:97205Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicConference posters Updating blood pressure targets in Singapore – insights from developing an ACE Clinical Guidance for hypertension managementhttps://isomer-user-content.by.gov.sg/68/554bd3d4-4bd1-4077-8001-30f7a802e2f3/ETPO006_updatingBPtargets.pdfurn:isomer:resource:97208Tue, 10 Sep 2024 00:00:00 +0800Global Evidence Summit (GES) 2024Prague, Czech RepublicConference posters Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Storyhttps://link.springer.com/article/10.1007/s41669-024-00491-wurn:isomer:resource:44498Tue, 23 Jul 2024 00:00:00 +0800PharmacoEconomicsJournal publications A New Process for Patients and Caregivers to Suggest Health Technologies for Funding Consideration in Singapore [PDF, 390 KB]https://isomer-user-content.by.gov.sg/68/0424e5fb-3eda-4ba7-911b-809955f0f98e/a-new-process-for-patients-and-caregivers-to-suggest-health-technologies-for-funding-consideration-in-singapore.pdfurn:isomer:resource:44452Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters Charting a Sustainable Way to Subsidize Implants in Singapore [PDF, 308 KB]https://isomer-user-content.by.gov.sg/68/4468124a-1739-4177-9b17-13abb7a3d4b6/charting-a-sustainable-way-to-subsidize-implants-in-singapore.pdfurn:isomer:resource:44459Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters Company-led Submission For Cancer Medicines: The Singapore Experience [PDF, 140 KB]https://isomer-user-content.by.gov.sg/68/ef7ec34c-88d1-41eb-b214-eebabc1d9712/company-led-submission-for-cancer-medicines--the-singapore-experience.pdfurn:isomer:resource:44460Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters Does Patient Input Add Value to Healthcare Decision-Making? A 2-Year Reflection on Patient Involvement Processes in Singapore [PDF, 672 KB]https://isomer-user-content.by.gov.sg/68/854d918f-b96c-488e-8292-e9c4ba23b5fa/does-patient-input-add-value-to-healthcare-decision-making--a-2-year-reflection-on-patient-involvement-processes-in-singapore.pdfurn:isomer:resource:44485Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters Establishing the Implant Subsidy List in Singapore: A Collaborative Approach between Health Technology Assessment and National Procurement Agencies [PDF, 1.84 MB]https://isomer-user-content.by.gov.sg/68/3f49a578-029a-4107-aca8-725ac4bf2408/establishing-the-implant-subsidy-list-in-singapore--a-collaborative-approach-between-health-technology-assessment-and-national-procurement-agencies.pdfurn:isomer:resource:44488Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters From Insight to Foresight: Singapore’s Experience in Horizon Scanning of Medical Technologies [PDF, 222 KB]https://isomer-user-content.by.gov.sg/68/5082bc4b-dbe9-4373-ac76-0117c44ab3ea/from-insight-to-foresight--singapore-s-experience-in-horizon-scanning-of-medical-technologies.pdfurn:isomer:resource:44491Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters Impact of a Consumer Panel to Inform Health Technology Assessments and Policy Development: The Singapore Experience [PDF, 654 KB]https://isomer-user-content.by.gov.sg/68/3bf83c91-5785-4d3d-8092-9a91c0378df1/impact-of-a-consumer-panel-to-inform-health-technology-assessments-and-policy-development--the-singapore-experience.pdfurn:isomer:resource:44496Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters Impact of the Cancer Drug List on Top 30 Cancer Drug Prices in Singapore’s Public Healthcare Sector [PDF, 146 KB]https://isomer-user-content.by.gov.sg/68/e6f9b0e5-8d54-48b4-afe1-62971435dd5d/impact-of-the-cancer-drug-list-on-top-30-cancer-drug-prices-in-singapore-s-public-healthcare-sector.pdfurn:isomer:resource:44497Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters Real-world Effectiveness of Umeclidinium and Umeclidinium/vilanterol for Chronic Obstructive Pulmonary Disease (COPD): A Singapore Database Study [PDF, 227 KB]https://isomer-user-content.by.gov.sg/68/402882a4-b961-4215-9d05-cd88e30884b0/real-world-effectiveness-of-umeclidinium-and-umeclidinium-vilanterol-for-chronic-obstructive-pulmonary-disease--copd---a-singapore-database-study.pdfurn:isomer:resource:44508Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters Scanning the Right Horizons: Does Singapore’s Horizon Scanning Identify and Assess the Relevant Technologies? [PDF, 138 KB]https://isomer-user-content.by.gov.sg/68/b429feff-e860-42c9-89bd-5bc121a7ba40/scanning-the-right-horizons--does-singapore-s-horizon-scanning-identify-and-assess-the-relevant-technologies-.pdfurn:isomer:resource:44512Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters Singapore’s Experience with Implementing and Monitoring Risk-Sharing Arrangements for Drugs in the Public Healthcare Sector [PDF, 210 KB]https://isomer-user-content.by.gov.sg/68/6295c4e6-f734-4c2d-a380-6931b87aaece/singapore-s-experience-with-implementing-and-monitoring-risk-sharing-arrangements-for-drugs-in-the-public-healthcare-sector.pdfurn:isomer:resource:44514Sat, 01 Jun 2024 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingSeville, SpainConference posters Helping patients become equal stakeholders in healthcare decision-making: The challenges and successes of patient involvement in Singapore [PDF, 768 KB]https://isomer-user-content.by.gov.sg/68/72c0c4a5-5249-40b9-bd29-181ab8bbbde1/helping-patients-become-equal-stakeholders-in-healthcare-decision-making--the-challenges-and-successes-of-patient-involvement-in-singapore.pdfurn:isomer:resource:44494Thu, 01 Feb 2024 00:00:00 +08001st International Society for Pharmacoeconomics & Outcomes Research (ISPOR)Student Network Asia-Pacific Region Conference (ISPAC) (Virtual)Conference posters Cost-utility analysis of sacituzumab govitecan versus chemotherapy for the treatment of metastatic triple-negative breast cancer in Singaporehttps://www.tandfonline.com/doi/full/10.1080/14737167.2023.2291155urn:isomer:resource:44482Vol. 24 - Issue 2Fri, 01 Dec 2023 00:00:00 +0800Expert Review of Pharmacoeconomics & Outcomes ResearchJournal publications Characteristics of Patients with Symptomatic Severe Aortic Stenosis Who Underwent Transcatheter Aortic Valve Implantation (TAVI): A Real-World Study in Singapore [PDF, 151 KB]https://isomer-user-content.by.gov.sg/68/b21a05ef-989b-48bd-b1c0-b481d743fa6c/characteristics-of-patients-with-symptomatic-severe-aortic-stenosis-who-underwent-transcatheter-aortic-valve-implantation--tavi---a-real-world-study-in-singapore.pdfurn:isomer:resource:44458Wed, 01 Nov 2023 00:00:00 +0800The Professional Society for Health Economics and Outcomes Research (ISPOR) EuropeCopenhagen, DenmarkConference posters Cost-Effectiveness Analysis of Molnupiravir Against Standard Care for Treating Mild to Moderate COVID-19 Infection in Singapore [PDF, 328 KB]https://isomer-user-content.by.gov.sg/68/b21f914a-1acb-4fa5-a30f-48dfbd16de44/cost-effectiveness-analysis-of-molnupiravir-against-standard-care-for-treating-mild-to-moderate-covid-19-infection-in-singapore.pdfurn:isomer:resource:44466Wed, 01 Nov 2023 00:00:00 +0800The Professional Society for Health Economics and Outcomes Research (ISPOR) EuropeCopenhagen, DenmarkConference posters Cost-Effectiveness of Inclisiran as Add-on Therapy to Standard-of-Care for the Secondary Prevention of Cardiovascular Events in Patients with Elevated LDL Cholesterol [PDF, 261 KB]https://isomer-user-content.by.gov.sg/68/989ab13b-6322-4615-8d00-025dba42dec0/cost-effectiveness-of-inclisiran-as-add-on-therapy-to-standard-of-care-for-the-secondary-prevention-of-cardiovascular-events-in-patients-with-elevated-ldl-cholesterol.pdfurn:isomer:resource:44475Wed, 01 Nov 2023 00:00:00 +0800The Professional Society for Health Economics and Outcomes Research (ISPOR) EuropeCopenhagen, DenmarkConference posters Real-world utilisation and outcomes of transcatheter mitral valve leaflet repair (TMVLR) in Asian patients with mitral regurgitation: A Singapore experience [PDF, 203 KB]https://isomer-user-content.by.gov.sg/68/6235ea09-4556-4ea6-94e5-185fdd058b40/real-world-utilisation-and-outcomes-of-transcatheter-mitral-valve-leaflet-repair--tmvlr--in-asian-patients-with-mitral-regurgitation--a-singapore-experience.pdfurn:isomer:resource:44511Wed, 01 Nov 2023 00:00:00 +0800The Professional Society for Health Economics and Outcomes Research (ISPOR) EuropeCopenhagen, DenmarkConference posters The association of ESMO-Magnitude of Clinical Benefit Scale scores and subsidy decisions of targeted therapies for solid tumours in Singapore [PDF, 275 KB]https://isomer-user-content.by.gov.sg/68/dd528e06-e0b2-4554-a229-1b9d21d4b235/the-association-of-esmo-magnitude-of-clinical-benefit-scale-scores-and-subsidy-decisions-of-targeted-therapies-for-solid-tumours-in-singapore.pdfurn:isomer:resource:44515Wed, 01 Nov 2023 00:00:00 +0800The Professional Society for Health Economics and Outcomes Research (ISPOR) EuropeCopenhagen, DenmarkConference posters Assessing frailty care gaps to inform evidence implementation designhttps://isomer-user-content.by.gov.sg/68/59c00cf4-612b-48e2-8f50-394c7214e710/ETPO022_2023_fraility.pdfurn:isomer:resource:97408Mon, 09 Oct 2023 00:00:00 +0800Evidence Implementation Summit (EIS) 2023Melbourne, AustraliaOral presentations Formative research – a critical step to support guidance adoptionhttps://isomer-user-content.by.gov.sg/68/208433db-84d8-419d-b843-fa0bb28e665c/ETPO023_2023_FR.pdfurn:isomer:resource:97409Mon, 09 Oct 2023 00:00:00 +0800Evidence Implementation Summit (EIS) 2023Melbourne, AustraliaOral presentations Impact of educational visiting on guidance adoption in asthmahttps://isomer-user-content.by.gov.sg/68/468d8133-6d54-42f0-9a9f-55949d71f48c/ETPO024_2023_asthmaEV.pdfurn:isomer:resource:97410Mon, 09 Oct 2023 00:00:00 +0800Evidence Implementation Summit (EIS) 2023Melbourne, AustraliaOral presentations A targeted scope for impactful clinical guidances: from asthma care gaps to recommendationshttps://isomer-user-content.by.gov.sg/68/aebc01ae-ebb9-49fd-80f6-acce02e22c39/ETPO021_2023_asthmascope.pdfurn:isomer:resource:97244Thu, 21 Sep 2023 00:00:00 +0800Guidelines International Network (GIN) 2023Glasglow, United KingdomOral presentations Healthcare professional involvement in the scoping of an ACE Clinical Guidance (ACG) on chronic kidney disease (CKD) – the Singapore experiencehttps://isomer-user-content.by.gov.sg/68/1917659f-4dc2-4a60-bedd-432a06bf241f/ETPO025_2023_CKDsurvey.pdfurn:isomer:resource:97525Thu, 21 Sep 2023 00:00:00 +0800Guidelines International Network (GIN) 2023Glasglow, United KingdomConference posters Prioritising systematic reviews for guidance development through mapping of international guideline recommendationshttps://isomer-user-content.by.gov.sg/68/1f34c064-439b-4dc8-86a4-070d92879a29/ETPO027_2023_PrioritisingSRs.pdfurn:isomer:resource:97527Thu, 21 Sep 2023 00:00:00 +0800Guidelines International Network (GIN) 2023Glasglow, United KingdomConference posters Updating clinical guidances sustainably – lessons learnt from ACE Clinical Guidances (ACGs)https://isomer-user-content.by.gov.sg/68/81d7ce5e-b65a-44b7-8402-ffcd4d617f6d/ETPO026_2023_UpdatingACGs.pdfurn:isomer:resource:97526Thu, 21 Sep 2023 00:00:00 +0800Guidelines International Network (GIN) 2023Glasglow, United KingdomConference posters Are We Ready for It? Developing Criteria to Include Artificial Intelligence Medical Devices (AI-MDs) For Health Technology Assessment (HTA) [PDF, 657 KB]https://isomer-user-content.by.gov.sg/68/93c405e3-fe1a-4e57-8700-d5a4ac3f54fc/are-we-ready-for-it--developing-criteria-to-include-artificial-intelligence-medical-devices--ai-mds--for-health-technology-assessment--hta-.pdfurn:isomer:resource:44455Thu, 01 Jun 2023 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingAdelaide, AustraliaConference posters Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Chemotherapy for Previously Treated HER2-Positive Gastric Cancer in Singapore [PDF, 568 KB]https://isomer-user-content.by.gov.sg/68/1e3ef327-185d-4a13-aae9-34c8c5cd8a1b/cost-effectiveness-analysis-of-trastuzumab-deruxtecan-versus-chemotherapy-for-previously-treated-her2-positive-gastric-cancer-in-singapore.pdfurn:isomer:resource:44473Thu, 01 Jun 2023 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingAdelaide, AustraliaConference posters Early Health Technology Assessment (HTA) of Medical Technologies to Inform Subsidy Decision-making in Singapore [PDF, 693 KB]https://isomer-user-content.by.gov.sg/68/ac71f7fa-2225-4d60-8abc-591545a25afc/early-health-technology-assessment--hta--of-medical-technologies-to-inform-subsidy-decision-making-in-singapore.pdfurn:isomer:resource:44486Thu, 01 Jun 2023 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingAdelaide, AustraliaConference posters Increasing Emergence of Novel Digital Health Technologies Identified Through Horizon Scanning [PDF, 550 KB]https://isomer-user-content.by.gov.sg/68/018da598-c7fc-4c59-abd3-5a433c1fc837/increasing-emergence-of-novel-digital-health-technologies-identified-through-horizon-scanning.pdfurn:isomer:resource:44499Thu, 01 Jun 2023 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingAdelaide, AustraliaConference posters Patient Involvement in Drug Evaluations to Inform Funding Decisions: A Singapore Case Study [PDF, 1.03 MB]https://isomer-user-content.by.gov.sg/68/b6ad9ca6-ecc7-4b2c-93b7-7255958a6c22/patient-involvement-in-drug-evaluations-to-inform-funding-decisions--a-singapore-case-study.pdfurn:isomer:resource:44504Thu, 01 Jun 2023 00:00:00 +0800Health Technology Assessment International (HTAi) Annual MeetingAdelaide, AustraliaConference posters What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forwardhttps://www.ijhpm.com/article_4398_1a1cd356710299767cda74bafbba4c45.pdfurn:isomer:resource:44517Vol. 12 - Issue 1Wed, 01 Mar 2023 00:00:00 +0800International Journal of Health Policy and ManagementJournal publications Horizon Scanning To Nominate Subsidy Evaluation Topics For Medical Technologies: Early Experience From Singaporehttps://www.doi.org/10.1017/S026646232200277Xurn:isomer:resource:44495Vol. 38 - Special Issue S1Sun, 01 Jan 2023 00:00:00 +0800International Journal of Technology Assessment in Health CareJournal publications Developing a New Region-Specific Preference-Based Measure in East and Southeast Asiahttps://www.valuehealthregionalissues.com/article/S2212-1099(22)00133-9/fulltexturn:isomer:resource:44484Regional Issues 37Tue, 01 Nov 2022 00:00:00 +0800Value in HealthJournal publications Real-world impact of a subsidy decision of sofosbuvir–velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomeshttps://onlinelibrary.wiley.com/doi/10.1002/jgh3.12850urn:isomer:resource:44510Vol. 7 - Issue 1Tue, 01 Nov 2022 00:00:00 +0800JGH OpenJournal publications Cost-effectiveness of transcatheter aortic valve implantation in patients with severe symptomatic aortic stenosis of intermediate surgical risk in Singaporehttps://pubmed.ncbi.nlm.nih.gov/35927703urn:isomer:resource:44481Vol. 22Mon, 01 Aug 2022 00:00:00 +0800BMC Health Services ResearchJournal publications Measuring Real-World Impact of Subsidy Decision on Sleep Tests Utilisation for the Diagnosis of Obstructive Sleep Apnoeahttps://www.sciencedirect.com/science/article/abs/pii/S1098301522014930urn:isomer:resource:44501Vol. 25 - Issue 7Fri, 01 Jul 2022 00:00:00 +0800Value in HealthJournal publications Real-World Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Patients with Non-Valvular Atrial Fibrillation (NVAF): A Retrospective Cohort Study in Singaporehttps://www.sciencedirect.com/science/article/abs/pii/S1098301522002959urn:isomer:resource:44507Vol. 25 - Issue 7Fri, 01 Jul 2022 00:00:00 +0800Value in HealthJournal publications Real-world evaluation of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors for managing type 2 diabetes mellitus: a retrospective multi-ethnic cohort studyhttps://link.springer.com/article/10.1007/s40200-022-01004-4urn:isomer:resource:44509Vol. 21Tue, 01 Mar 2022 00:00:00 +0800Journal of Diabetes & Metabolic DisordersJournal publications Cost-effectiveness of daratumumab in combination with lenalidomide and dexamethasone for relapsed and/or refractory multiple myelomahttps://www.tandfonline.com/doi/abs/10.1080/14737167.2022.2017285?journalCode=ierp20urn:isomer:resource:44474Vol. 22 - Issue 2Wed, 01 Dec 2021 00:00:00 +0800Expert Review of Pharmacoeconomics & Outcomes ResearchJournal publications Effect of drug subsidy policy on empagliflozin utilisation in Singapore: An interrupted time series analysis [PDF, 388 KB]https://isomer-user-content.by.gov.sg/68/6a6e3235-3ea9-48cb-845b-5f6153d8cc12/effect-of-drug-subsidy-policy-on-empagliflozin-utilisation-in-singapore--an-interrupted-time-series-analysis.pdfurn:isomer:resource:44487Fri, 01 Oct 2021 00:00:00 +080013th Asian Conference on Pharmacoepidemiology (Virtual)Seoul, KoreaConference posters Measuring the impact of subsidy decision on bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in Singapore [PDF, 7.42 MB]https://isomer-user-content.by.gov.sg/68/f82ffb51-2c78-466c-8fdc-2cf43a9c3bee/measuring-the-impact-of-subsidy-decision-on-bilateral-cochlear-implants-for-children-with-severe-to-profound-sensorineural-hearing-loss-in-singapore.pdfurn:isomer:resource:44502Fri, 01 Oct 2021 00:00:00 +08009th HTAsiaLink Annual Virtual ConferenceConference posters Real-world data for measuring the impact of health technology assessment of drugs in Singapore [PDF, 6.32 MB]https://isomer-user-content.by.gov.sg/68/513a52fe-2e4f-4b5d-a0ac-6249b6955750/real-world-data-for-measuring-the-impact-of-health-technology-assessment-of-drugs-in-singapore.pdfurn:isomer:resource:44506Fri, 01 Oct 2021 00:00:00 +08009th HTAsiaLink Annual Virtual ConferenceConference posters Cost-effectiveness analysis of MRI targeted biopsy strategies for diagnosing prostate cancer in Singaporehttps://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-021-06916-0urn:isomer:resource:44467Vol. 21 - Article 909Wed, 01 Sep 2021 00:00:00 +0800BMC Health Services ResearchJournal publications A review of implementation frameworks to operationalize health technology assessment recommendations for medical technologies in the Singapore settinghttps://www.cambridge.org/core/journals/international-journal-of-technology-assessment-in-health-care/article/review-of-implementation-frameworks-to-operationalize-health-technology-assessment-recommendations-for-medical-technologies-in-the-singapore-setting/3FC5992685A5C2B12A83A2E784CF6A26urn:isomer:resource:44454Vol. 37 - Issue 1Thu, 01 Apr 2021 00:00:00 +0800International Journal of Technology Assessment in Health CareJournal publications Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singaporehttps://www.sciencedirect.com/science/article/pii/S0264410X21003212?via%3Dihuburn:isomer:resource:44472Vol. 39 - Issue 16Thu, 01 Apr 2021 00:00:00 +0800VaccineJournal publications Cost-effectiveness of olaparib maintenance therapy when used with and without restriction byBRCA1/2mutation status for platinum-sensitive relapsed ovarian cancerhttps://www.tandfonline.com/doi/abs/10.1080/14737167.2021.1890587urn:isomer:resource:44476Vol. 21 - Issue 3Mon, 01 Mar 2021 00:00:00 +0800Expert Review of Pharmacoeconomics & Outcomes ResearchJournal publications A landscape analysis of health technology assessment capacity in the Association of South‑East Asian Nations regionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879649urn:isomer:resource:44451Vol. 19Mon, 01 Feb 2021 00:00:00 +0800Health Research and Policy SystemsJournal publications Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singaporehttps://www.tandfonline.com/doi/abs/10.1080/14737167.2021.1880323?journalCode=ierp20urn:isomer:resource:44477Vol. 21 - Issue 3Mon, 01 Feb 2021 00:00:00 +0800Expert Review of Pharmacoeconomics & Outcomes ResearchJournal publications Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singaporehttps://www.tandfonline.com/doi/full/10.1080/02770903.2020.1837158urn:isomer:resource:44456Vol. 59 - Issue 1Thu, 01 Oct 2020 00:00:00 +0800Journal of AsthmaJournal publications Cost-effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singaporehttps://onlinelibrary.wiley.com/doi/10.1002/cnr2.1308urn:isomer:resource:44478Vol. 4 - Issue 1Thu, 01 Oct 2020 00:00:00 +0800Cancer ReportsJournal publications Changes in prescribing practice of sodium-glucose co-transporter 2 inhibitors and dipeptidyl peptidase 4 inhibitors in Singapore [PDF, 77 KB]https://isomer-user-content.by.gov.sg/68/7e266845-3728-4bd3-a9f4-3f04c45eea1b/changes-in-prescribing-practice-of-sodium-glucose-co-transporter-2-inhibitors-and-dipeptidyl-peptidase-4-inhibitors-in-singapore.pdfurn:isomer:resource:44457Tue, 01 Sep 2020 00:00:00 +080036th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) (Virtual)Conference posters Cost-effectiveness analysis of osimertinib for first line treatment of locally advanced or metastatic EGFR mutation positive non-small cell lung cancer in Singaporehttps://www.tandfonline.com/doi/abs/10.1080/13696998.2020.1819822urn:isomer:resource:44468Vol 23 - Issue 11Tue, 01 Sep 2020 00:00:00 +0800Journal of Medical EconomicsJournal publications Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forwardhttps://www.cambridge.org/core/journals/international-journal-of-technology-assessment-in-health-care/article/realworld-data-for-health-technology-assessment-for-reimbursement-decisions-in-asia-current-landscape-and-a-way-forward/307E7C910FA736E085DD2FC42BE95315urn:isomer:resource:44505Vol. 36 - Issue 5Tue, 01 Sep 2020 00:00:00 +0800International Journal of Technology Assessment in Health CareJournal publications Cost utility analysis of tisagenlecleucel vs salvage chemotherapy in the treatment of relapsed/refractory diffuse large B-cell lymphoma from Singapore’s healthcare system perspectivehttps://www.tandfonline.com/doi/abs/10.1080/13696998.2020.1808981?journalCode=ijme20urn:isomer:resource:44483Vol 23 - Issue 11Sat, 01 Aug 2020 00:00:00 +0800Journal of Medical EconomicsJournal publications Cost-effectiveness analysis of atezolizumab in advanced triple negative breast cancerhttps://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-020-05445-6urn:isomer:resource:4446420 - Article 581Mon, 01 Jun 2020 00:00:00 +0800BMC Health Services ResearchJournal publications Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancerhttps://www.tandfonline.com/doi/abs/10.1080/13696998.2020.1775620?journalCode=ijme20urn:isomer:resource:44469Vol. 23 - Issue 9Mon, 01 Jun 2020 00:00:00 +0800Journal of Medical EconomicsJournal publications Funding of treatments for rare diseases in Singapore [PDF, 295 KB]https://isomer-user-content.by.gov.sg/68/26a58764-19ac-482e-ad4f-2a1c2b850422/funding-of-treatments-for-rare-diseases-in-singapore.pdfurn:isomer:resource:44492Mon, 01 Jun 2020 00:00:00 +080017th HTA International Annual Meeting (Virtual)Beijing, ChinaConference posters Cost-effectiveness of sequential urate lowering therapies for the management of gout in Singaporehttps://www.tandfonline.com/doi/full/10.1080/13696998.2020.1757456urn:isomer:resource:44480Vol. 23 - Issue 8Fri, 01 May 2020 00:00:00 +0800Journal of Medical EconomicsJournal publications Towards greater impact in health technology assessment: horizon scanning for new and emerging technologies in Singaporehttps://www.cambridge.org/core/journals/international-journal-of-technology-assessment-in-health-care/article/abs/towards-greater-impact-in-health-technology-assessment-horizon-scanning-for-new-and-emerging-technologies-in-singapore/2C3906DCE9ABF800E01AD5550F3BA87Aurn:isomer:resource:44516Vol. 36 - Issue 4Fri, 01 May 2020 00:00:00 +0800International Journal of Technology Assessment in Health CareJournal publications Landscape analysis of health technology assessment (HTA): systems and practices in Asiahttps://safe.menlosecurity.com/https://www.cambridge.org/core/journals/international-journal-of-technology-assessment-in-health-care/article/landscape-analysis-of-health-technology-assessment-hta-systems-and-practices-in-asia/A7967FF2B9175B8F938C5BD6BA8FC087urn:isomer:resource:44500Vol. 35 - Issue 6Tue, 01 Oct 2019 00:00:00 +0800International Journal of Technology Assessment in Health CareJournal publications Cost effectiveness analysis of bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears in Singaporehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695111urn:isomer:resource:44465Thu, 01 Aug 2019 00:00:00 +0800PLOS OneJournal publications Meta-Analysis of omalizumab and ciclosporin for chronic spontaneous urticaria [PDF, 80 KB]https://isomer-user-content.by.gov.sg/68/ef4c6a49-a93d-4345-80f3-5ef7b9a77828/meta-analysis-of-omalizumab-and-ciclosporin-for-chronic-spontaneous-urticaria.pdfurn:isomer:resource:44503Sat, 01 Jun 2019 00:00:00 +080016th HTA International Annual MeetingCologne, GermanyConference posters Health technology assessment and its use in drug policies: Singaporehttps://www.sciencedirect.com/science/article/pii/S2212109918300566urn:isomer:resource:44493Vol. 18Wed, 01 May 2019 00:00:00 +0800Value in HealthJournal publications Cost-effectiveness analysis of sunitinib versus interferon-alfa for first-line treatment of advanced and/or metastatic renal cell carcinoma in Singaporehttps://www.cambridge.org/core/journals/international-journal-of-technology-assessment-in-health-care/article/costeffectiveness-analysis-of-sunitinib-versus-interferonalfa-for-firstline-treatment-of-advanced-andor-metastatic-renal-cell-carcinoma-in-singapore/5B5E4785734BFFFDF98A7D94BDAE2911urn:isomer:resource:44471Vol. 35 - Issue 2Fri, 01 Mar 2019 00:00:00 +0800International Journal of Technology Assessment in Health CareJournal publications Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186767urn:isomer:resource:44461Vol. 18Mon, 01 Oct 2018 00:00:00 +0800International Journal of Chronic Obstructive Pulmonary DiseaseJournal publications Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) in chronic obstructive pulmonary disease: A systematic review and network meta-analysis [PDF, 81 KB]https://isomer-user-content.by.gov.sg/68/b28a5ca0-7db6-4e4b-9d95-e6a74d54ff8e/comparative-efficacy-of-inhaled-medications--ics-laba--lama--lama-laba-and-sama--in-chronic-obstructive-pulmonary-disease--a-systematic-review-and-network-meta-analysis.pdfurn:isomer:resource:44462Sat, 01 Sep 2018 00:00:00 +08008th ISPOR Asia PacificTokyo, JapanConference posters Cost-effectiveness analysis of sunitinib versus interferon-alfa for first-line treatment of advanced and/or metastatic renal cell carcinoma in Singapore [PDF, 83 KB]https://isomer-user-content.by.gov.sg/68/1495c08c-7f6a-4bea-a7dd-300a030e37e8/cost-effectiveness-analysis-of-sunitinib-versus-interferon-alfa-for-first-line-treatment-of-advanced-and-or-metastatic-renal-cell-carcinoma-in-singapore.pdfurn:isomer:resource:44470Sat, 01 Sep 2018 00:00:00 +08008th ISPOR Asia PacificTokyo, JapanConference posters Fluorodeoxyglucose positron emission tomography with computerised tomography for oncological indications: a pragmatic approach to guide subsidy decisions [PDF, 60 KB]https://isomer-user-content.by.gov.sg/68/1e3b58ac-2e87-493f-a5ba-6d9e5c62f157/fluorodeoxyglucose-positron-emission-tomography-with-computerised-tomography-for-oncological-indications--a-pragmatic-approach-to-guide-subsidy-decisions.pdfurn:isomer:resource:44490Sat, 01 Sep 2018 00:00:00 +08008th ISPOR Asia PacificTokyo, JapanConference posters A pilot trial of value-based pricing for medical devices [PDF, 70 KB]https://isomer-user-content.by.gov.sg/68/2d85f73d-4891-4fea-a5cb-29dca9b6ea86/a-pilot-trial-of-value-based-pricing-for-medical-devices.pdfurn:isomer:resource:44453Fri, 01 Jun 2018 00:00:00 +080015th HTA International Annual MeetingVancouver, CanadaConference posters Evolution of national drug evaluation processes in Singapore [PDF, 119 KB]https://isomer-user-content.by.gov.sg/68/844b0464-ec53-4833-b767-c2d4d1578ff9/evolution-of-national-drug-evaluation-processes-in-singapore.pdfurn:isomer:resource:44489Fri, 01 Jun 2018 00:00:00 +080015th HTA International Annual MeetingVancouver, CanadaConference posters Selection of non-drug medical technologies for evaluation in Singapore [PDF, 100 KB]https://isomer-user-content.by.gov.sg/68/f841bb6a-e02b-4c5e-a849-0bcbc7eb58df/selection-of-non-drug-medical-technologies-for-evaluation-in-singapore.pdfurn:isomer:resource:44513Fri, 01 Jun 2018 00:00:00 +080015th HTA International Annual MeetingVancouver, CanadaConference posters Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspectivehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872570urn:isomer:resource:44463Vol. 18Thu, 01 Mar 2018 00:00:00 +0800BMC CancerJournal publications Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fractionhttps://www.tandfonline.com/doi/full/10.1080/13696998.2017.1387119urn:isomer:resource:44479Vol. 21 - Issue 2Sun, 01 Oct 2017 00:00:00 +0800Journal of Medical EconomicsJournal publications